Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer

Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer

BACKGROUND: To evaluate the prognostic value of E-cadherin, CD44, and MSH2 expression for colorectal cancer (CRC) and construct nomograms that can predict prognosis. METHODS: We retrospectively analyzed the expression of E-cadherin, CD44, and MSH2 in 223 paraffin-embedded stage II and III CRC specim...

Full description

Bibliographic Details
Main Authors:	Jinmiao Qu, Yuming Jiang, Hao Liu, Haijun Deng, Jiang Yu, Xiaolong Qi, Weiting Ge, Guoxin Li
Format:	Article
Language:	English
Published:	Elsevier 2017-04-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523316302303

Similar Items

Expression of CD44, PCNA and E-cadherin in pterygium tissues
by: Humeyra Yıldırım, et al.
Published: (2024-04-01)

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
by: Zhenpeng Wang, et al.
Published: (2019-04-01)

CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion.
by: Grégoire F Le Bras, et al.
Published: (2011-01-01)

Prognostic Significance of CSN2, CD8, and MMR Status-Associated Nomograms in Patients with Colorectal Cancer
by: Bing Zhu, et al.
Published: (2018-10-01)

Il-6 and MSH3 in colorectal carcinoma: Expression, relationship, and prognostic significance in 171 colorectal carcinoma cases
by: Elif Kolay Bayram, et al.
Published: (2024-12-01)

Expression of MLH-1, PMS-2, MSH-2, MSH-6 markers and histopathological evaluation in colorectal cancer
by: Syed Ali Baqher Hussaini, et al.
Published: (2024-07-01)

Expression of MSH-6 immunohistochemistry marker in colorectal cancer
by: M. Ramezani, et al.
Published: (2021-05-01)

Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients
by: Muhammad Usman Rashid, et al.
Published: (2019-10-01)

The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer
by: Peng Jiang, et al.
Published: (2024-04-01)

Podoplanin, E-cadherin, beta-catenin, and CD44v6 in recurrent ameloblastoma: their distribution patterns and relevance
by: Siar, C.H., et al.
Published: (2015)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
by: Myung-Giun Noh, et al.
Published: (2017-08-01)

Cytoplasmic MSH2 Related to Genomic Deletions in the MSH2/EPCAM Genes in Colorectal Cancer Patients With Suspected Lynch Syndrome
by: Lin Dong, et al.
Published: (2021-05-01)

Correlations between MSH2 and MSH6 Concentrations in Different Biological Fluids and Clinicopathological Features in Colorectal Adenocarcinoma Patients and Their Contribution to Fast and Early Diagnosis of Colorectal Adenocarcinoma
by: Alexandru Adrian Bratei, et al.
Published: (2023-12-01)

Prognostic value of CD44 in renal cell carcinoma
by: Mahmood Kabiri, et al.
Published: (2006-11-01)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
by: Nayê Balzan Schneider, et al.
Published: (2018-05-01)

The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma.
by: Renjie Wang, et al.
Published: (2016-01-01)

Quantitative Immunohistochemical Analyses of the Expression of E-Cadherin, Thrombomodulin, CD44H and CD44v6 in Primary Tumours of pharynx/larynx Squamous Cell Carcinoma and their Lymph Node Metastases
by: Rocío Hernández Gaspar, et al.
Published: (1999-01-01)

The prognostic role of γδ T cells in colorectal cancer based on nomogram
by: Rulan Ma, et al.
Published: (2023-10-01)

Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy.
by: Brewster, S, et al.
Published: (1999)

Comparison of E- cadherin and CD44 Marker Expression in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma
by: Khadijeh Abdal, et al.
Published: (2022-12-01)

Differential expression of Oct-4, CD44, and E-cadherin in eutopic and ectopic endometrium in ovarian endometriomas and their correlations with clinicopathological variables
by: Ceyda Sancakli Usta, et al.
Published: (2020-11-01)

Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report
by: Tiansong Zhang, et al.
Published: (2024-01-01)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
by: Jungang Liu, et al.
Published: (2020-04-01)

Establishment and Validation of a Prognostic Nomogram for Predicting Postoperative Overall Survival in Advanced Stage III–IV Colorectal Cancer Patients
by: Pengwei Lou, et al.
Published: (2024-11-01)

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
by: Jinming Fu, et al.
Published: (2023-07-01)

Prognostic significance of a panel of two biomarkers (E-cadherin and CD105) in laryngeal cancer
by: Elvir Zvrko, et al.
Published: (2024-01-01)

<it>MSH6 </it>syndrome
by: Suchy Janina, et al.
Published: (2008-06-01)

CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt
by: Adel Gomaa Gabr, et al.
Published: (2023-12-01)

The Landscape of the Tumor-Infiltrating Immune Cell and Prognostic Nomogram in Colorectal Cancer
by: Jiateng Zhong, et al.
Published: (2022-05-01)

Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
by: Jae-Ghi Lee, et al.
Published: (2025-01-01)

CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
by: Kenta Tsunekuni, et al.
Published: (2019-10-01)

The prognostic value and immunological role of CD44 in pan-cancer study
by: Shaoyong Chen, et al.
Published: (2023-04-01)

circMSH3 is a potential biomarker for the diagnosis of colorectal cancer and affects the distant metastasis of colorectal cancer
by: Jian Shen, et al.
Published: (2023-11-01)

Parameters of Reserpine Analogs That Induce MSH2/MSH6-Dependent Cytotoxic Response
by: Aksana Vasilyeva, et al.
Published: (2010-01-01)

Tissue Cadherin 17 (CDH17): An Important Prognostic Determinant of Colorectal Cancer Using Digital Image Analysis
by: Lui Ng, et al.
Published: (2024-12-01)

Correction: Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
by: Jae-Ghi Lee, et al.
Published: (2025-02-01)

Prognostic significance of nomograms integrating IL‐37 expression, neutrophil level, and MMR status in patients with colorectal cancer
by: Bing Zhu, et al.
Published: (2018-08-01)

Pretreatment detection of circulating and tissue CD133+ CD44+ cancer stem cells as a prognostic factor affecting the outcomes in Egyptian patients with colorectal cancer
by: Zahran AM, et al.
Published: (2019-02-01)

Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma
by: Sharmilla Devi Rajkumar, et al.
Published: (2021-07-01)

Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis.
by: Jiang Chen, et al.
Published: (2014-01-01)